NASDAQ: YBYuanbao Inc Stock
$16.38-0.12 (-0.73%)
Updated May 1, 2026
YB Price
$16.38
Fair Value Price
N/A
Market Cap
$756.30M
52 Week Low
$14.04
52 Week High
$31.00
P/E
2x
P/B
1.54x
P/S
1.18x
PEG
N/A
Dividend Yield
N/A
Revenue
$641.22M
Earnings
$86.19M
Gross Margin
96.2%
Operating Margin
16.19%
Profit Margin
45.9%
Debt to Equity
0.39
Operating Cash Flow
$212M
Beta
1.09
Next Earnings
Jun 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
YB Overview
Yuanbao Inc., through its subsidiaries, provides online insurance distribution and services in the People's Republic of China. The company offers medical, critical illness, life, and other insurance products. It also provides system services, including precise marketing, analytics, and other system services. Yuanbao Inc. was incorporated in 2019 and is headquartered in Beijing, the People's Republic of China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine YB's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: App
Industry Rating
B
YB
Ranked#45 of 168
Ranked#45 of 168
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $77.86 | A | |
| $45.08 | A | |
| $2.44 | A |
Be the first to know about important YB news, forecast changes, insider trades & much more!
YB News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how YB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
YB is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
YB is good value based on its earnings relative to its share price (2x), compared to the US market average (18.84x)
P/E vs Market Valuation
YB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more YB due diligence checks available for Premium users.
Valuation
YB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
2x
Industry
35.39x
Market
18.84x
YB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
YB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
YB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.54x
Industry
4.72x
YB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
YB's financial health
Profit margin
Revenue
$166.9M
Net Income
-$151.2M
Profit Margin
28.7%
YB's Earnings (EBIT) of $103.80M... subscribe to Premium to read more.
Interest Coverage Financials
YB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$661.3M
Liabilities
$186.0M
Debt to equity
0.39
YB's short-term assets ($653.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
YB's short-term assets ($653.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
YB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
YB's operating cash flow ($219.23M)... subscribe to Premium to read more.
Debt Coverage Financials
YB vs App Stocks
Yuanbao Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.